SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-019769
Filing Date
2021-10-06
Accepted
2021-10-06 17:09:15
Documents
23
Period of Report
2021-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20210930.htm   iXBRL 8-K 41202
2 EX-10.1 ex101_waiverfor8k.htm EX-10.1 19655
3 EX-99.1 ex991_125noteprincipalwaiv.htm EX-99.1 16366
7 GRAPHIC ex101_waiverfor8k001.jpg GRAPHIC 247796
8 GRAPHIC ex101_waiverfor8k002.jpg GRAPHIC 262927
9 GRAPHIC ex101_waiverfor8k003.jpg GRAPHIC 242829
10 GRAPHIC ex101_waiverfor8k004.jpg GRAPHIC 96536
11 GRAPHIC ex101_waiverfor8k005.jpg GRAPHIC 41795
12 GRAPHIC ex101_waiverfor8k006.jpg GRAPHIC 72627
13 GRAPHIC ex101_waiverfor8k007.jpg GRAPHIC 33955
14 GRAPHIC ex101_waiverfor8k008.jpg GRAPHIC 104623
15 image_0a.jpg GRAPHIC 62743
  Complete submission text file 0001628280-21-019769.txt   1840087

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20210930.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20210930_lab.xml EX-101.LAB 24975
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20210930_pre.xml EX-101.PRE 13181
16 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20210930_htm.xml XML 11260
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211310370
SIC: 2834 Pharmaceutical Preparations